Guangyu Liu

11PUBLICATIONS
13CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 15, 2026
Bisphosphate nucleotidase 1 promotes progression and docetaxel resistance in triple-negative breast cancer via STUB1-mediated destabilization of LIMA1.

Yun-Xiao Ling, Lisa Andriani, Shao-Ying Yang

|Nov 25, 2025
Efficacy and Safety of Neoadjuvant TQB2102 in Locally Advanced or Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Randomized, Open-Label, Multicenter, Phase II Trial.

Jun-Jie Li, Wen-Juan Zhang, Xiao-Hua Zeng

|Jan 04, 2025
A prospective, phase II, neoadjuvant study based on chemotherapy sensitivity in HR+/HER2- breast cancer-FINEST study.

Li Chen, Wen-Ya Wu, Fei Liang

|May 30, 2023
Repeated core needle biopsy and targeted fine-needle aspiration to optimize axillary surgery after neoadjuvant chemotherapy in node-positive breast cancer: prospective clinical study.

Si-Yu Wu, Jian-Wei Li, Ying Zhang

|Apr 12, 2023
The comparison of efficacy and safety evaluation of vacuum-assisted Elite 10-G system and the traditional BARD 14-G core needle in breast diagnosis: an open-label, parallel, randomized controlled trial.

Ying Zhang, Junjie Li, Miao Mo

|Jan 30, 2023
Correction to: All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits.

Huai-Liang Wu, Zi-Yin Luo, Zong-Lin He

Pageof 2

Frequent Collaborators

2 joint publications

Zhi-Ming Shao

2 joint publications

Da-Qiang Li

2 joint publications

Si-Yu Wu

1 joint publications

Jin-Xiao Ren